ELV Elevance Health Inc

$349.99

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Elevance Health is poised for a potentially strong earnings report, with the whisper number suggesting an EPS of $9.86, notably above the consensus estimate of $9.16. This optimism reflects market confidence in Elevance's strategic initiatives and operational efficiencies, which have been pivotal in navigating the complex healthcare landscape. With a substantial revenue estimate of $48.14 billion, the company is expected to leverage its robust market position, underscored by a market cap of over $78 billion, to drive growth and shareholder value. As investors await the earnings release on July 17, the focus will be on how Elevance's strategic decisions have translated into financial performance, particularly in light of the whisper number's higher expectations.

Updated On 10/6/2025

About Elevance Health Inc

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.

Website: https://www.elevancehealth.com

Sector
FINANCE
Industry
HOSPITAL & MEDICAL SERVICE PLANS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1156039
Address
120 MONUMENT CIRCLE, INDIANAPOLIS, IN, US
Valuation
Market Cap
$96.11B
P/E Ratio
16.53
PEG Ratio
0.76
Price to Book
2.33
Performance
EPS
$25.68
Dividend Yield
1.61%
Profit Margin
3.38%
ROE
14.80%
Technicals
50D MA
$414.38
200D MA
$450.86
52W High
$560.90
52W Low
$360.70
Fundamentals
Shares Outstanding
226M
Target Price
$501.23
Beta
0.78

ELV EPS Estimates vs Actual

● Estimated
● Actual

ELV News & Sentiment

Oct 02, 2025 • Zacks Commentary BULLISH
Humana Benefits From Rising Premiums Amid High Benefit Ratio
HUM gains from rising premiums, Medicare growth and CenterWell expansion, but faces pressure from high benefit ratios and costs.
Sep 30, 2025 • Zacks Commentary BULLISH
Cigna to Support Cleerly's AI Cardiovascular Imaging Solutions
CI expands coverage to Cleerly's AI cardiovascular imaging, boosting access, early detection and digital healthcare adoption.
Sep 26, 2025 • Zacks Commentary NEUTRAL
Centene Sits at 13.25X P/E: Time to Load Up or Look Away for Now?
CNC's low 13.25X P/E may look attractive, but falling margins, heavy debt and shrinking memberships paint a tougher picture.
Sep 24, 2025 • CNBC NEUTRAL
The Trump administration is changing Covid, childhood vaccine recommendations - here's what it means for you
Several health experts say there are steps Americans can take to navigate the new guidance and try to secure the vaccines they or their children want or need.
Sep 23, 2025 • Benzinga NEUTRAL
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. ( NASDAQ: CYTK ) ; Elevance Health Inc. ( NYSE: ELV ) ; Fluor Corporation ( NYSE: FLR ) ; and Fly-E Group, Inc. ( NASDAQ: FLYE ) : Grabar Law Office is Investigating Claims on Your Behalf - Cytokinetics ( NASDAQ:CYTK ) , Elevance Health ( NYSE:ELV )
PHILADELPHIA, Sept. 23, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. CYTK. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Sep 19, 2025 • CNBC NEUTRAL
RFK Jr.'s vaccine panel weakens Covid shot recommendations, calling it an individual decision
The group also voted to emphasize that the Covid vaccine is beneficial for those at high risk of severe illness from the disease.
Sentiment Snapshot

Average Sentiment Score:

0.182
50 articles with scored sentiment

Overall Sentiment:

Bullish

ELV Reported Earnings

Apr 22, 2025
Mar 31, 2025 (Pre market)
0.49 Surprise
  • Reported EPS: $11.97
  • Estimate: $11.48
  • Whisper: —
  • Surprise %: 4.3%
Jan 23, 2025
Dec 31, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $3.84
  • Estimate: $3.80
  • Whisper: —
  • Surprise %: 1.1%
Oct 17, 2024
Sep 30, 2024 (Pre market)
-1.29 Surprise
  • Reported EPS: $8.37
  • Estimate: $9.66
  • Whisper: —
  • Surprise %: -13.3%
Jul 17, 2024
Jun 30, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $10.12
  • Estimate: $10.01
  • Whisper: —
  • Surprise %: 1.1%
Apr 18, 2024
Mar 31, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $10.64
  • Estimate: $10.53
  • Whisper: —
  • Surprise %: 1.0%
Jan 24, 2024
Dec 31, 2023 (Pre market)
-0.02 Surprise
  • Reported EPS: $5.62
  • Estimate: $5.64
  • Whisper: —
  • Surprise %: -0.3%
Oct 18, 2023
Sep 30, 2023 (Pre market)
0.55 Surprise
  • Reported EPS: $8.99
  • Estimate: $8.44
  • Whisper: —
  • Surprise %: 6.5%
Jul 19, 2023
Jun 30, 2023 (Pre market)
0.24 Surprise
  • Reported EPS: $9.04
  • Estimate: $8.80
  • Whisper: —
  • Surprise %: 2.7%
Apr 19, 2023
Mar 31, 2023 (Pre market)
0.2 Surprise
  • Reported EPS: $9.46
  • Estimate: $9.26
  • Whisper: —
  • Surprise %: 2.2%

Financials